HilleVax, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 123.57 million compared to USD 159.81 million a year ago. Basic loss per share from continuing operations was USD 3.04 compared to USD 5.89 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.62 USD | +11.39% | +7.57% | -9.66% |
May. 09 | HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.66% | 623M | |
+28.99% | 49.18B | |
+0.82% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.30% | 26.09B | |
-22.63% | 18.71B | |
+8.06% | 13.26B | |
+32.17% | 12.32B | |
-0.52% | 11.99B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- HilleVax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023